Cancer drug discovery Archives

News & Features

Genialis Uses Machine Learning to Personalize Cancer Treatment Outcomes

Christina Jackson -

April 12, 2024

News & Features

MEK Inhibitor Sparks Hope as Novel Treatment for Common Skin Cancer

Alisa Kirkin -

October 12, 2023

News & Features

Time of Day May Be Important for Cancer Diagnosis and Treatment

Chris Anderson -

March 29, 2023

Destruction of leukaemia cell in blood cancer

News & Features

Promising Menin Inhibitor Results from Leukemia Trial Published

Malorye Branca -

March 16, 2023

Book Reviews

For Blood and Money

Kathy Vuksanaj -

February 10, 2023

News & Features

Novel Approach Detects Targets in Heterogenous Cancers

Anjali A. Sarkar, PhD -

March 18, 2022

News & Features

Scorpion Therapeutics, AstraZeneca Ink Deal Focused on “Undruggable” Cancer Targets.

Chris Anderson -

January 13, 2022

Triple negative breast cancer cell undergoing retraction and apoptosis

News & Features

Triple Negative Breast Cancer’s Newest Target: MAPK4

Sophia Ktori -

January 12, 2022

Diseased lung, conceptual illustration to illustrate pulmonary fibrosis

Informatics

Cancer Drugs Could Be Used to Treat Pulmonary Hypertension

Helen Albert -

October 21, 2021

Medicines With Bottle On Purple Background

News & Features

Drugs Developed for Other Illnesses Might Be Repurposed for Cancer Treatment

Chris Anderson -

January 21, 2020

12 Page 1 of 2

Study Identifies Key Factors for Long-Term Weight Loss with GLP-1 Medications

AI Effectively Allocates Resources in Pandemic

New Therapy Shows Promise in Targeting Tau Tangles in Alzheimer’s Disease

AFib Three Times More Common than Thought

Better Heart Health Early on May Offset Risk of Pregnancy-Related Hypertension

Cancer drug discovery

Genialis Uses Machine Learning to Personalize Cancer Treatment Outcomes

MEK Inhibitor Sparks Hope as Novel Treatment for Common Skin Cancer

Time of Day May Be Important for Cancer Diagnosis and Treatment

Promising Menin Inhibitor Results from Leukemia Trial Published

For Blood and Money

Novel Approach Detects Targets in Heterogenous Cancers

Scorpion Therapeutics, AstraZeneca Ink Deal Focused on “Undruggable” Cancer Targets.

Triple Negative Breast Cancer’s Newest Target: MAPK4

Cancer Drugs Could Be Used to Treat Pulmonary Hypertension

Drugs Developed for Other Illnesses Might Be Repurposed for Cancer Treatment

Related Content

AI Effectively Allocates Resources in Pandemic

Five Features Underlie Immunotherapy Response

Antibiotic Use Linked to Increased Risk of Inflammatory Bowel Disease

New Tool Predicts Severity of TNBC